Kirr Marbach & Co’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-41,114
Closed -$6.88M 60
2019
Q2
$6.88M Sell
41,114
-1,736
-4% -$240K 1.69% 30
2019
Q1
$6.27M Sell
42,850
-2,300
-5% -$333K 1.53% 35
2018
Q4
$6.04M Sell
45,150
-1,268
-3% -$208K 1.67% 31
2018
Q3
$8.84M Buy
46,418
+1,014
+2% +$186K 1.96% 28
2018
Q2
$7.57M Sell
45,404
-2,078
-4% -$334K 1.64% 32
2018
Q1
$7.99M Sell
47,482
-830
-2% -$139K 1.67% 33
2017
Q4
$7.9M Sell
48,312
-886
-2% -$159K 1.59% 34
2017
Q3
$10.1M Buy
49,198
+865
+2% +$201K 2.2% 26
2017
Q2
$11.7M Sell
48,333
-660
-1% -$155K 2.62% 18
2017
Q1
$11.7M Sell
48,993
-3,565
-7% -$830K 2.61% 20
2016
Q4
$11M Sell
52,558
-5,414
-9% -$1.12M 2.28% 24
2016
Q3
$13.4M Sell
57,972
-379
-0.6% -$92.6K 2.66% 15
2016
Q2
$13.5M Buy
58,351
+2,020
+4% +$466K 2.89% 12
2016
Q1
$15.1M Sell
56,331
-128
-0.2% -$36.6K 3.06% 10
2015
Q4
$17.6M Sell
56,459
-1,203
-2% -$358K 3.51% 5
2015
Q3
$15.7M Buy
57,662
+237
+0.4% +$72.8K 3.19% 11
2015
Q2
$17.4M Buy
57,425
+632
+1% +$189K 3.05% 12
2015
Q1
$16.9M Buy
+56,793
New +$16.2M 3.03% 13

Other funds holding AGN

Kirr Marbach & Co's AGN Position: Q3 2019 in Review

Kirr Marbach & Co sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 41,114 shares — an estimated $6.88M sold.

Kirr Marbach & Co first reported a position in AGN in Q1 2015 and held it in 18 quarters. The position peaked at $17.6M in Q4 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Kirr Marbach & Co reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Kirr Marbach & Co sold 41,114 Allergan plc shares in Q3 2019, an estimated $6.88M.
  • Kirr Marbach & Co first reported a position in Allergan plc in Q1 2015 and held it in 18 quarters.
  • Kirr Marbach & Co's Allergan plc position peaked at $17.6M in Q4 2015.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Kirr Marbach & Co's 13F filing for Q3 2019, filed 15 Oct 2019.